Wilson Nick, Edwards Richard, Hoek Janet, Thomson George, Blakely Tony, van der Deen Frederieke Sanne, Crane Julian
Public Health, University of Otago, Wellington.
N Z Med J. 2015 Nov 20;128(1425):88-96.
While e-cigarette usage has grown rapidly in New Zealand and around the world, the scientific evidence base regarding the net benefits and risks of these types of products at the population level remains uncertain. The health-based policy experience is also minimal. Here, we analyse plausible future regulatory options for e-cigarettes that the New Zealand Government could explore, and that further research could help clarify. These options include: (1) a full free market (an option we doubt is desirable for multiple reasons); (2) controlled increased access through: (a) pharmacy only, (b) pharmacy only plus sales by prescription/ to licensed vapers; (c) additional controls through non-profit supply/distribution (eg, public hospital pharmacies); (3) increased restrictions compared with current (eg, adopting a complete ban on self-imports and use). In addition, we consider mechanisms to improve product quality and safety, and argue that policy makers should take great care when regulating e-cigarettes, given the scientific uncertainty and the role of commercial vested interests.
虽然电子烟在新西兰及全球的使用量增长迅速,但关于这类产品在人群层面的净效益和风险的科学证据基础仍不明确。基于健康的政策经验也很少。在此,我们分析了新西兰政府可以探索的、未来对电子烟可能的监管选项,以及进一步的研究可能有助于阐明的选项。这些选项包括:(1)完全自由的市场(出于多种原因,我们怀疑这一选项是否可取);(2)通过以下方式有控制地增加获取途径:(a)仅通过药店销售,(b)仅通过药店销售并加上凭处方销售/向有执照的电子烟使用者销售;(c)通过非营利性供应/分发(如公立医院药房)进行额外管控;(3)与当前相比增加限制(如全面禁止自行进口和使用)。此外,我们考虑了提高产品质量和安全性的机制,并认为鉴于科学上的不确定性以及商业既得利益的作用,政策制定者在监管电子烟时应格外谨慎。